Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEAM vs GSK✓SelectedUSD · GSKTEAM vs GSK performance historyLatest closeAs of-5.98%11/17
Stock and ETF performance explorer

TEAM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-23.8%
GSK return
+58.9%
Excess return
-82.7%
Maximum drawdown
-82.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.0%-2.3%-3.7%-6.2%
7D-5.1%-3.0%-2.1%-5.4%
30D-32.2%+0.4%-32.5%-32.1%
3M-11.0%-1.2%-9.8%-11.0%
6M+61.2%+0.9%+60.3%+62.0%
YTD-13.1%+4.0%-17.0%-13.7%
1Y-3.5%+7.3%-10.7%-4.1%
3Y-23.8%+57.1%-80.9%-22.5%
All-23.8%+58.9%-82.7%-22.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling